Bourne Research has launched The Bourne Report - Medical Device Quarterly, a report series dedicated to covering the use of MEMS and Nanotechnology in medicine.
Geared toward physicians, life science researchers, medical device OEMs, hospital administrators and insurers, each quarterly report covers the next-generation technologies, products, applications and trends that are not only improving patient diagnosis and treatment, but will ultimately reduce healthcare costs.
"MEMS devices have already had a small, but profound impact on cardiology, diabetes and point-of-care diagnostics, and both MEMS and Nanotechnology combined are showing signs of doing the same for a variety of drug delivery mechanisms," says Marlene Bourne, Principal Analyst with Bourne Research.
"Implantable MEMS pressure sensors for remote patient monitoring is a reality today, as is the use of silver nanoparticle-based coatings for infection control of anesthesiology catheters, and this is only the tip of the iceberg."
Bourne Research reports that revenues of BioMEMS (the use of MEMS in biotechnology) alone accounted for nearly $1 billion in 2005.
The diversity of BioMEMS devices currently being used is impressive, and ranges from inertial and pressure sensors, to nozzles, pumps, valves and other devices in applications as far reaching as asthma inhalers, surgical instrumentation and pharmaceutical production.
The gains made to date with Nanotechnology are equally notable, with nanoparticle-based composites and coatings already playing a role in orthopedics, dentistry and more.